Ferrere, through its team in Uruguay, has represented Terminal Cuenca del Plata (TCP), the public-private joint venture specialising in containers at the port of Montevideo, in securing two loans for $443m to expand its logistics
Tags :Uruguay
Barros & Errázuriz has counselled Reuse, a Chilean marketplace dedicated to the repair and sale of electronic equipment, in structuring a USD $4,510,000 financing round. This transaction was completed on 10 April, and involved the jurisdictions
Bruchou & Funes de Rioja has advised the shareholders of UK-based TPCG Group, owner of TPCG Valores (Argentina) and TPCG Financial Services Agente de Valores (Uruguay), and the shareholders of Southern Trust (Argentina), on the
Bruchou & Funes de Rioja, Cleary Gottlieb Steen & Hamilton LLP and Posadas Posadas & Vecino have advised The Clorox Company on the sale of its operations in Argentina, Uruguay and Paraguay to an investment
Ferrere, through its team in Uruguay, has advised Avolta, a global travel experience company of Swiss origin, in a joint venture with Corporación América Airports (CAAP), an airport operator that manages 53 airports in 6
Ferrere has announced the promotion of Federico Lemos Lorenzo (pictured) to partner of the firm, effective 1 January 2024. Federico has more than a decade of experience in Banking and Finance and leads FERRERE’s Fintech group.
Ferrere, through its team in Uruguay, has advised Itaú Uruguay on the acquisition of 40% of Handy, one of the fastest growing fintechs in the country. The advice involved carrying out the due diligence process of
Ferrere, through its team in Uruguay, has advised Trailer Films in the pre-production, production and post-production stages of the film “Higuita: El camino del escorpión”. The film, released in early November, is about the
The latest issue of The Latin American Lawyer brings the most current and relevant content of the last few months. As usual, in both versions we present our On the move section, dedicated to highlighting
Carey has locally represented Viatris in the sale of marketing and intellectual property rights to a portfolio of well-known branded products in Latin America, such as Lipitor, Viagra, Lyrica, Zoloft, Norvasc and Celebrex, to South
